ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.487,56
-0,61%
S&P 500
5.631,22
0,28%
Dow Jones
40.211,72
0,00%
Euro vs US Dollar
1,09018
0,02%
Bitcoin
63.968,68
-1,36%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. OptimizeRx Corporation (OPRX)

  7. OptimizeRx Corporation (OPRX) News

OPRX

OptimizeRx (OPRX)

OptimizeRx Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPRX
DatumZeitQuelleÜberschriftSymbolFirma
21/12/201822h56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
20/12/201822h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
20/12/201822h35Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OPRXOptimizeRx Corporation
20/12/201814h33Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
20/12/201814h32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
18/12/201823h21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
18/12/201823h11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OPRXOptimizeRx Corporation
18/12/201814h52GlobeNewswire Inc.OptimizeRx Announces Pricing of Public Offering of Common StockNASDAQ:OPRXOptimizeRx Corporation
17/12/201823h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OPRXOptimizeRx Corporation
17/12/201822h21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
17/12/201822h01GlobeNewswire Inc.OptimizeRx Announces Proposed Public Offering of Common StockNASDAQ:OPRXOptimizeRx Corporation
12/12/201812h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:OPRXOptimizeRx Corporation
11/12/201812h10Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)NASDAQ:OPRXOptimizeRx Corporation
10/12/201821h14Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:OPRXOptimizeRx Corporation
30/11/201822h22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
30/11/201817h00GlobeNewswire Inc.OptimizeRx Joins MSCI USA Microcap IndexNASDAQ:OPRXOptimizeRx Corporation
20/11/201815h17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
13/11/201823h15Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:OPRXOptimizeRx Corporation
09/11/201817h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
08/11/201814h47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPRXOptimizeRx Corporation
07/11/201822h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
07/11/201814h31GlobeNewswire Inc.OptimizeRx to Ring Nasdaq Closing Bell on Friday, November 16NASDAQ:OPRXOptimizeRx Corporation
06/11/201814h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
05/11/201822h06Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OPRXOptimizeRx Corporation
05/11/201822h01GlobeNewswire Inc.OptimizeRx Reports Third Quarter 2018 Results; Net Revenue Up 75% to a Record $5.4 Million, Driving $0.02 EPSNASDAQ:OPRXOptimizeRx Corporation
29/10/201813h23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
25/10/201817h52GlobeNewswire Inc.OptimizeRx to Present at ROTH Technology Corporate Access Day on November 14, 2018NASDAQ:OPRXOptimizeRx Corporation
24/10/201817h24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
23/10/201814h31GlobeNewswire Inc.OptimizeRx Sets Third Quarter 2018 Conference Call for Monday, November 5, 2018 at 4:30 p.m. ETNASDAQ:OPRXOptimizeRx Corporation
17/10/201814h46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPRXOptimizeRx Corporation
 Showing the most relevant articles for your search:NASDAQ:OPRX

Kürzlich von Ihnen besucht

NYSE
NKE
Nike
USOTC
ADDYY
Adidas (QX)
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
CCOM
US500
US 500
CCOM
US30
US 30
COIN
SOLUSD
Solana
CCOM
US100
US Tech 100
NYSE
JPM
JP Morgan Chase
TG
DTE
Deutsche Telekom
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
DBI
MDAX
MDAX
TG
432
Arbor Metals
NYSE
KO
Coca Cola
USOTC
BASFY
BASF (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten